International Business Machines Corporation (NYSE:IBM) saw its stock climb 3.45% on Monday, closing at $299.52, marking the sixth consecutive session of gains. The rally added approximately $9.4 billion to the company's market capitalization based on 939.88 million shares outstanding. In after-hours trading, shares were quoted at $299.00.
The move outpaced the broader market, with the S&P 500 gaining 0.72% and the Dow Jones Industrial Average rising 0.29%. Despite the strong performance, trading volume was 7.17 million shares, below the 65-day average of 8.56 million, according to MarketWatch.
Analyst Targets and Consensus Gap
The latest rally has brought IBM's closing price to within 1.14% of the average 12-month price target of $302.94, as compiled by Google Finance from 17 analysts. The consensus includes 12 buy ratings and five holds, with no sell recommendations. However, some bullish analysts are widening the gap from the consensus.
Bank of America Securities analyst Wamsi Mohan raised his price target to $330 from $315 while reiterating a buy rating. This implies a potential upside of 10.2% from Monday's close. Other notable targets include Wedbush's Daniel Ives at $350 (buy), Morgan Stanley's Erik Woodring at $267 (hold), and J.P. Morgan's Brian Essex at $291 (buy, raised from previous).
BofA's Bullish Thesis
BofA's optimism extends beyond a modest earnings beat. The firm now values IBM at 21 times projected 2027 enterprise-value-to-free-cash-flow, well above the historical median of 13 times. Mohan attributes this higher multiple to an "improving growth and FCF trajectory with Red Hat," according to Investor's Business Daily.
Key forecasts from BofA include Q2 revenue of $18.0 billion (3.2% organic growth), adjusted EPS of $3.05, and full-year 2026 revenue of $71.4 billion, up from a prior estimate of $71.1 billion. The firm also expects 2026 EPS of $12.47, compared to $12.10 previously, with a free cash flow view boosted by Confluent's contribution of $340 million in Q2.
Quantum Computing News
IBM also announced a quantum computing milestone on Monday. Researchers at Oak Ridge National Laboratory, Cleveland Clinic, and IBM used quantum computing to determine nine molecular structures of a material related to tritium production for fusion energy. Jerry Chow, IBM's CTO of quantum-centric supercomputing, stated that the findings demonstrate quantum technology is "now a practical scientific tool."
However, the stock's move was not solely driven by quantum news. The rally reflects broader confidence in IBM's software mix and free cash flow generation.
Earnings Outlook
IBM's Q2 earnings, tentatively scheduled for July 22, will be a key test. In April, the company reported Q1 revenue of $15.9 billion, up 9% year-over-year, with software sales rising 11% and infrastructure up 15%. Free cash flow came in at $2.2 billion. CEO Arvind Krishna noted that "AI continues to be a tailwind." IBM maintained its 2026 guidance of over 5% constant-currency revenue growth and approximately $1 billion in additional annual free cash flow.
If IBM raises its guidance, it could support the higher free-cash-flow multiple BofA envisions. However, if the company sticks with its April outlook, shares are already near the average target and trade above several recent price targets.
Shares are currently 9.9% below their 52-week high of $332.46 set in June. The stock's ability to break through resistance will depend on Q2 results and forward guidance.
